One problem with that concept and that's the fact that it would be ILLEGAL for him to market the product for any indication for which it has not been approved by the FDA. To date, Actipatch has ONLY been approved for treatment of swelling following eye surgery, by prescription only. Taking a trip around the country to market it for any other purpose would land him with heavy fines and possibly jail time.
Market Data 
Markets 
AI
